Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington’s disease mice (original) (raw)

• Albers DS, Beal MF (2000) Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J Neural Transm Suppl 59:131–154
  Google Scholar
• Arteaga S, Andrade-Cetto A, Cárdenas R (2005) Larrea tridentata (Creosote bush), an abundant plant of Mexican and US-American deserts and its metabolite nordihydroguaiaretic acid. J Ethnopharmacol 98:231–239
  Article PubMed CAS Google Scholar
• Beal MF (1995) Aging, energy and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357–366
  Article PubMed CAS Google Scholar
• Beal MF, Ferrante RJ (2004) Experimental therapeutics in transgenic mouse models of Huntington’s disease. Nat Rev Neurosci 5:373–384
  Article PubMed CAS Google Scholar
• Bosco DA, Fowler DM, Zhang Q, Nieva J, Powers ET, Wentworth P Jr et al (2006) Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat Chem Biol 2:249–253
  Article PubMed CAS Google Scholar
• Browne SE, Beal MF (2006) Oxidative damage in Huntington’s disease pathogenesis. Antioxid Redox Signal 8:2061–2073
  Article PubMed CAS Google Scholar
• Comporti M (1998) Lipid peroxidation and biogenic aldehydes: from the identification of 4-hydroxynonenal to further achievements in biopathology. Free Radic Res 28:623–635
  Article PubMed CAS Google Scholar
• Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B et al (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington’s disease mice. J Neurosci 23:9418–9427
  PubMed CAS Google Scholar
• Fischbeck KH (2001) Polyglutamine expansion neurodegenerative disease. Brain Res Bull 56:161–163
  Article PubMed CAS Google Scholar
• Fujimoto N, Kohta R, Kitamura S, Honda H (2004) Estrogenic activity of an antioxidant, nor dihydroguaiaretic acid (NDGA). Life Sci 74:1417–1425
  Article PubMed CAS Google Scholar
• Goodman Y, Steiner MR, Steiner SM, Mattson MP (1994) Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res 654:171–176
  Article PubMed CAS Google Scholar
• Hall ED, Andrus PK, Oostveen JA, Fleck TJ, Gurney ME (1998) Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. J Neurosci Res 53:66–77
  Article PubMed CAS Google Scholar
• Hamaguchi T, Ono K, Murase A, Yamada M (2009) Phenolic compounds prevent Alzheimer’s pathology through different effects on the amyloid-beta aggregation pathway. Am J Pathol 175:2557–2565
  Article PubMed CAS Google Scholar
• Hersch SM, Ferrante RJ (1997) Neuropathology and pathophysiology of Huntington’s disease. In: Watts RL, Koller WC (eds) Movement disorders: neurologic principles and practice. McGraw-Hill, New York, pp 503–518
• Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983
  Article Google Scholar
• Lee JM, Ivanova EV, Seong IS, Cashorali T, Kohane I, Gusella JF, MacDonald ME (2007) Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism. PLoS Genet 3:e135
  Article PubMed Google Scholar
• Levine MS, Klapstein GJ, Koppel A, Gruen E, Cepeda C, Vargas ME et al (1999) Enhanced sensitivity to _N_-methyl-d-aspartate receptor activation in transgenic and knockin mouse models of Huntington’s disease. J Neurosci Res 58:515–532
  Article PubMed CAS Google Scholar
• Li Y, Maher P, Schubert D (1997) A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19:453–463
  Article PubMed CAS Google Scholar
• Li X, Sapp E, Chase K, Comer-Tierney LA, Masso N, Alexander J, Reeves P, Kegel KB, Valencia A, Esteves M, Aronin N, Difiglia M (2009) Disruption of Rab11 activity in a knock-in mouse model of Huntington’s disease. Neurobiol Dis 36:374–383
  Article PubMed CAS Google Scholar
• Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493–506
  Article PubMed CAS Google Scholar
• McGrath LT, McGleenon BM, Brennan S, McColl D, McILroy S, Passmore AP (2001) Increased oxidative stress in Alzheimer’s disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM 94:485–490
  Article PubMed CAS Google Scholar
• Montine TJ, Neely MD, Quinn JF, Beal MF, Markesbery WR, Roberts LJ et al (2002) Lipid peroxidation in aging brain and Alzheimer’s disease. Free Radic Biol Med 33:620–626
  Article PubMed CAS Google Scholar
• Neely MD, Sidell KR, Graham DG, Montine TJ (1999) The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. J Neurochem 72:2323–2333
  Article PubMed CAS Google Scholar
• Neely MD, Boutte A, Milatovic D, Montine TJ (2005) Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction. Brain Res 1037:90–98
  Article PubMed CAS Google Scholar
• Nicholls DG, Ward MW (2000) Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci 23:166–174
  Article PubMed CAS Google Scholar
• Ono K, Hasegawa K, Yoshiike Y, Takashima A, Yamada M, Naiki H (2002) Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer’s beta-amyloid fibrils in vitro. J Neurochem 81:434–440
  Article PubMed CAS Google Scholar
• Ono K, Yamada M (2006) Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. J Neurochem 97:105–115
  Article PubMed CAS Google Scholar
• Orr AL, Li S, Wang CE, Li H, Wang J, Rong J, Xu X, Mastroberardino PG, Greenamyre JT, Li XJ (2008) N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci 28:2783–2792
  Article PubMed CAS Google Scholar
• Oyamada R, Hayashi M, Katoh Y, Tsuchiya K, Mizutani T, Tominaga I et al (2006) Neurofibrillary tangles and deposition of oxidative products in the brain in cases of myotonic dystrophy. Neuropathology 26:107–114
  Article PubMed Google Scholar
• Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ et al (2002) Early mitochondrial calcium defects in Huntington’s disease are a direct effect of polyglutamines. Nat Neurosci 5:731–736
  PubMed CAS Google Scholar
• Qahwash IM, Boire A, Lanning J, Krausz T, Pytel P, Meredith SC (2007) Site-specific effects of peptide lipidation on beta-amyloid aggregation and cytotoxicity. J Biol Chem 282:36987–36997
  Article PubMed CAS Google Scholar
• Ratan RR, Ryu H, Lee J, Mwidau A, Neve RL (2002) In vitro model of oxidative stress in cortical neurons. Methods Enzymol 352:183–190
  Article PubMed CAS Google Scholar
• Ryu H, Lee J, Olofsson BA, Mwidau A, Dedeoglu A, Escudero M et al (2003) Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an SP1-dependent pathway. Proc Natl Acad Sci USA 100:4281–4286
  Article PubMed CAS Google Scholar
• Ryu H, Lee J, Zaman K, Kubilis J, Ferrante RJ, Ross BD et al (2003) SP1 and SP3 are oxidative stress-inducible, anti-death transcription factors in cortical neurons. J Neurosci 23:3597–3606
  PubMed CAS Google Scholar
• Ryu H, Ferrante RJ (2005) Emerging chemotherapeutic strategies for Huntington’s disease. Expert Opin Emerg Drugs 10:345–363
  Article PubMed CAS Google Scholar
• Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA et al (2006) ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington’s disease. Proc Natl Acad Sci USA 103:19176–19181
  Article PubMed CAS Google Scholar
• Sawa A, Wiegand GW, Cooper J, Margolis RL, Sharp AH, Lawler JF Jr et al (1999) Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 5:1194–1198
  Article PubMed CAS Google Scholar
• Schaur RJ (2003) Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol Aspects Med 24:149–159
  Article PubMed CAS Google Scholar
• Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA et al (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8:397–407
  Article PubMed CAS Google Scholar
• Sexton A, McDonald M, Cayla C, Thiemermann C, Ahluwalia A (2007) 12-Lipoxygenase-derived eicosanoids protect against myocardial ischemia/reperfusion injury via activation of neuronal TRPV1. FASEB J 21:2695–2703
  Article PubMed CAS Google Scholar
• Shishido Y, Furushiro M, Hashimoto S, Yokokura T (2001) Effect of nordihydroguaiaretic acid on behavioral impairment and neuronal cell death after forebrain ischemia. Pharmacol Biochem Behav 69:469–474
  Article PubMed CAS Google Scholar
• Siegel SJ, Bieschke J, Powers ET, Kelly JW (2007) The oxidative stress metabolite 4 hydroxynonenal promotes Alzheimer protofibril formation. Biochemistry 46:1503–1510
  Article PubMed CAS Google Scholar
• Trostchansky A, Lind S, Hodara R, Oe T, Blair IA, Ischiropoulos H et al (2006) Interaction with phospholipids modulates alpha-synuclein nitration and lipid-protein adduct formation. Biochem J 393:343–349
  Article PubMed CAS Google Scholar
• Truant R, Atwal RS, Burtnik A (2007) Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington’s disease. Prog Neurobiol 83:211–227
  Article PubMed CAS Google Scholar
• Trushina E, McMurray CT (2007) Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 145:1233–1248
  Article PubMed CAS Google Scholar
• Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 44:559–577
  Article PubMed CAS Google Scholar
• Vonsattel JP (2008) Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol 115:55–69
  Article PubMed Google Scholar
• Zarkovic K (2003) 4-Hydroxynonenal and neurodegenerative diseases. Mol Aspects Med 24:293–303
  Article PubMed CAS Google Scholar